Background: Peanut allergy is a common food allergy with potentially life-threatening implications. Early oral immunotherapy for peanut allergy (P-EOIT) has been shown to be effective and safe in research and specialty clinic settings. Provision of P-EOIT in primary care would make it available to more patients.
View Article and Find Full Text PDFThe voltage-gated sodium channel remains a rich area for the development of novel blockers. In this study we used comparative molecular field analysis (CoMFA), a ligand-based design strategy, to generate a 3D model based upon local anesthetics, hydantoins, and alpha-hydroxyphenylamides to elucidate a SAR for their binding site in the neuronal sodium channel. Correlation by partial least squares (PLS) analysis of in vitro sodium channel binding activity (expressed as pIC(50)) and the CoMFA descriptor column generated a final non-cross-validated model with q(2)=0.
View Article and Find Full Text PDFNew bidentate and tridentate ligands that feature selenium donors, namely the bis- and tris(2-seleno-1-methylimidazolyl)hydroborato ligands [BseMe] and [TseMe], have been constructed via the reaction of MBH4(M=Na, K) with 1-methylimidazole-2-selone. Comparison of the structure of {[BseMe]ZnI}2 with its sulfur counterpart, [BmMe]ZnI, demonstrates that the seleno ligand exhibits a greater tendency than the mercapto ligand to bridge two metal centers, while comparison of [TseMe]Re(CO)3 and [TseMes]Re(CO)3 indicates that the [TseMe] ligand is more electron donating and less sterically demanding than the [TseMes] ligand.
View Article and Find Full Text PDFLinear nickel nitrosyl compounds supported by tridentate nitrogen and selenium ligands, namely the tris(3,5-dimethylpyrazolyl)hydroborato and tris(2-seleno-1-mesitylimidazolyl)hydroborato complexes, [TpMe2]NiNO and [TseMes]NiNO, have been synthesized and structurally characterized by X-ray diffraction. Computational studies demonstrate that the linear nitrosyl ligand behaves as a trivalent X3 ligand such that the Ni-N interaction has multiple bond character.
View Article and Find Full Text PDFA new tripodal ligand that features three selenium donors, namely the tris(2-seleno-1-mesitylimidazolyl)hydroborato ligand, [Tse(Mes)], has been constructed via the reaction of KBH(4) with 1-mesitylimidazole-2-selone; comparison of the IR spectroscopic data of [Tse(Mes)]Re(CO)(3) with those of a variety of related LRe(CO)(3) complexes demonstrates that the [Tse(Mes)] ligand is more strongly electron donating than Cp, Cp*, [Tp], [Tp(Me(2))] and [Tm(Mes)] ligands.
View Article and Find Full Text PDF1-Mesityl-1,3-dihydro-imidazole-2-selone, (seim(Mes))H, may be obtained from 1-mesitylimidazole via (i) deprotonation with Bu(n)Li, (ii) treatment with elemental selenium, and (iii) addition of HCl(aq). Structural characterization of (seim(Mes))H by X-ray diffraction demonstrates that the compound exists as the selone rather than selenol tautomer, a result that is in accord with DFT calculations. Solutions of (seim(Mes))H are oxidized by air to give bis(1-mesitylimidazol-2-yl)diselenide, (seim(Mes))(2).
View Article and Find Full Text PDFA series of iridium and rhodium complexes that feature M-->B dative bonds, namely [kappa(3)-B,S,S-B(mim(R))3]Ir(CO)(PPh3)H (R = But, Ph) and [kappa4-B(mim(Bu)t)3]M(PPh3)Cl (M = Rh, Ir), has been synthesized via (i) the reactions of Ir(PPh3)2(CO)Cl with [Tm(Bu)t]Tl and [Tm(Ph)]Li and (ii) the reactions of (COD)M(PPh3)Cl with [Tm(Bu)t]K. The complexes have been structurally characterized by X-ray diffraction, thereby demonstrating the presence of a M-->B dative bond in each complex. The nature of the M-->B interaction in these complexes has been addressed by computational methods which indicate that the metal centers possess a d(6) configuration.
View Article and Find Full Text PDF